Transforming growth factor-β induces Cdk2 relocalization to the cytoplasm coincident with dephosphorylation of retinoblastoma tumor suppressor protein

Breast Cancer Research

Volumn 6, Issue 2, 2004, Pages

  Brown, Kimberly A ^a,b   Roberts, Richard L ^c   Arteaga, Carlos L ^a,b,c   Law, Brian K ^a,b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cyclin dependent kinase 2; localization; p21; p27; transforming growth factor

Indexed keywords

CDK2 PROTEIN, HUMAN; CDK2 PROTEIN, MOUSE; CDKN1B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; HRAS PROTEIN, HUMAN; PROTEIN P21; RAPAMYCIN; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN;

ACTIVE TRANSPORT; ANIMAL; ARTICLE; CELL LINE; CELL NUCLEUS; CHEMISTRY; CYTOLOGY; CYTOPLASM; DRUG ANTAGONISM; ENZYMOLOGY; EPITHELIUM CELL; HUMAN; KERATINOCYTE; MAMMARY GLAND; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE; UDDER;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOPLASM; EPITHELIAL CELLS; HUMANS; KERATINOCYTES; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS P21(RAS); RETINOBLASTOMA PROTEIN; SIROLIMUS; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEINS;

EID: 9144271919     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr762     Document Type: Article

References (46)

1. J. Keski-Oja E.B. Leof R.M. Lyons R.J. Coffey Jr H.L. Moses Transforming growth factors and control of neoplastic cell growth J Cell Biochem 1987 33 95 107 1:CAS:528:DyaL2sXhsFCjsL0%3D 10.1002/jcb.240330204 3553215
2. D.F. Pierce Jr A.E. Gorska A. Chytil K.S. Meise D.L. Page R.J. Coffey Jr H.L. Moses Mammary tumor suppression by transforming growth factor β1 transgene expression Proc Natl Acad Sci USA 1995 92 4254 4258 1:CAS:528:DyaK2MXls1altbo%3D 10.1073/pnas.92.10.4254 7753792 41922
3. E.P. Bottinger J.L. Jakubczak D.C. Haines K. Bagnall L.M. Wakefield Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene Cancer Res 1997 57 5564 5570 1:CAS:528:DyaK2sXotVGnt78%3D 9407968
4. R. Derynck R.J. Akhurst A. Balmain TGF-β signaling in tumor suppression and cancer progression Nat Genet 2001 29 117 129 1:CAS:528:DC%2BD3MXnsFKgt7c%3D 10.1038/ng1001-117 11586292
5. D.L. Kelly A. Rizzino Growth regulatory factors and carcinogenesis: the roles played by transforming growth factor beta, its receptors and signaling pathways AntiCancer Res 1999 19 4791 4807 1:CAS:528:DC%2BD3cXhsFaiu7Y%3D 10697593
6. M. Kretzschmar Transforming growth factor-beta and breast cancer: Transforming growth factor-beta/SMAD signaling defects and cancer Breast Cancer Res 2000 2 107 115 1:CAS:528:DC%2BD3cXlsF2qsLY%3D 10.1186/bcr42 11250700 139432
7. E. Ziv J. Cauley P.A. Morin R. Saiz W.S. Browner Association between the T29→C polymorphism in the transforming growth factor β1 gene and breast cancer among elderly white women: the study of osteoporotic fractures JAMA 2001 285 2859 2863 1:CAS:528:DC%2BD3MXkvVOntrY%3D 10.1001/jama.285.22.2859 11401606
8. B. Pasche P. Kolachana K. Nafa J. Satagopan Y.G. Chen R.S. Lo D. Brener D. Yang L. Kirstein C. Oddoux H. Ostrer P. Vineis L. Varesco S. Jhanwar L. Luzzatto J. Massague K. Offit TβR-I(6A) is a candidate tumor susceptibility allele Cancer Res 1999 59 5678 5682 1:CAS:528:DyaK1MXnslyht7Y%3D 10582683
9. J.A. Pietenpol J.T. Holt R.W. Stein H.L. Moses Transforming growth factor β1 suppression of c-mycgene transcription: role in inhibition of keratinocyte proliferation Proc Natl Acad Sci USA 1990 87 3758 3762 1:CAS:528:DyaK3cXkslWrsrs%3D 10.1073/pnas.87.10.3758 2187192 53982
10. M.G. Alexandrow M. Kawabata M. Aakre H.L. Moses Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor β1 Proc Natl Acad Sci USA 1995 92 3239 3243 1:CAS:528:DyaK2MXltFSnt7c%3D 10.1073/pnas.92.8.3239 7724545 42141
11. G.J. Hannon D. Beach p15INK4B is a potential effector of TGF-β-induced cell cycle arrest Nature 1994 371 257 261 1:CAS:528:DyaK2cXmsVOqsbk%3D 10.1038/371257a0 8078588
12. K. Polyak J.Y. Kato M.J. Solomon C.J. Sherr J. Massague J.M. Roberts A. Koff p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest Genes Dev 1994 8 9 22 1:CAS:528:DyaK2cXktVWku7c%3D 10.1101/gad.8.1.9 8288131
13. S.C. Cipriano Y.Q. Chen Insensitivity to growth inhibition by TGF-β1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells Oncogene 1998 17 1549 1556 1:CAS:528:DyaK1cXms1Ogtrg%3D 10.1038/sj.onc.1202069 9794232
14. J.K. Schwarz C.H. Bassing I. Kovesdi M.B. Datto M. Blazing S. George X.F. Wang J.R. Nevins Expression of the E2F1 transcription factor overcomes type β transforming growth factor-mediated growth suppression Proc Natl Acad Sci USA 1995 92 483 487 1:CAS:528:DyaK2MXjt12qtrs%3D 10.1073/pnas.92.2.483 7831315 42765
15. J.M. Li P.P. Hu X. Shen Y. Yu X.F. Wang E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor β through E2F binding sites Proc Natl Acad Sci USA 1997 94 4948 4953 1:CAS:528:DyaK2sXjtlegtrw%3D 10.1073/pnas.94.10.4948 9144170 24611
16. A. Iavarone J. Massague E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest Mol Cell Biol 1999 19 916 922 1:CAS:528:DyaK1MXhvFyhsg%3D%3D 10.1128/MCB.19.1.916 9858615 83949
17. M.J. West M. Stoneley A.E. Willis Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway Oncogene 1998 17 769 780 1:CAS:528:DyaK1cXls1Smsbs%3D 10.1038/sj.onc.1201990 9715279
18. W.G. Morice G. Wiederrecht G.J. Brunn J.J. Siekierka R.T. Abraham Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes J Biol Chem 1993 268 22737 22745 1:CAS:528:DyaK3sXlslersrY%3D 8226784
19. s6kintegrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes Mol Cell Biol 1999 19 4729 4738 1:CAS:528:DyaK1MXktVCgsLY%3D 10.1128/MCB.19.7.4729 10373522 84271
20. B.K. Law A. Chytil N. Dumont E.G. Hamilton M.E. Waltner-Law M.E. Aakre C. Covington H.L. Moses Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells Mol Cell Biol 2002 22 8184 8198 1:CAS:528:DC%2BD38Xos1yhs7Y%3D 10.1128/MCB.22.23.8184-8198.2002 12417722 134072
21. C. Hall D.M. Nelson X. Ye K. Baker J.A. DeCaprio S. Seeholzer M. Lipinski P.D. Adams HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression Mol Cell Biol 2001 21 1854 1865 1:CAS:528:DC%2BD3MXhtlGhtro%3D 10.1128/MCB.21.5.1854-1865.2001 11238922 86753
22. H. Ruffner W. Jiang A.G. Craig T. Hunter I.M. Verma BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site Mol Cell Biol 1999 19 4843 4854 1:CAS:528:DyaK1MXktVCgtr4%3D 10.1128/MCB.19.7.4843 10373534 84283
23. W. Jiang N.J. Wells T. Hunter Multistep regulation of DNA replication by Cdk phosphorylation of HsCdc6 Proc Natl Acad Sci USA 1999 96 6193 6198 1:CAS:528:DyaK1MXksFKksL8%3D 10.1073/pnas.96.11.6193 10339564 26858
24. J. Zhao B.K. Kennedy B.D. Lawrence D.A. Barbie A.G. Matera J.A. Fletcher E. Harlow NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription Genes Dev 2000 14 2283 2297 1:CAS:528:DC%2BD3cXntVSksrw%3D 10.1101/gad.827700 10995386 316937
25. 199by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication J Biol Chem 2001 276 21529 21537 1:CAS:528:DC%2BD3MXksFGlu7s%3D 10.1074/jbc.M100014200 11278991
26. E.S. Knudsen J.Y. Wang Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation Mol Cell Biol 1997 17 5771 5783 1:CAS:528:DyaK2sXmtlOjtLk%3D 10.1128/MCB.17.10.5771 9315635 232425
27. Y. Geng W. Whoriskey M.Y. Park R.T. Bronson R.H. Medema T. Li R.A. Weinberg P. Sicinski Rescue of cyclin D1 deficiency by knockin cyclin E Cell 1999 97 767 777 1:CAS:528:DyaK1MXjvFOju7g%3D 10.1016/S0092-8674(00)80788-6 10380928
28. Y. Geng Q. Yu E. Sicinska M. Das J.E. Schneider S. Bhattacharya W.M. Rideout R.T. Bronson H. Gardner P. Sicinski Cyclin E ablation in the mouse Cell 2003 114 431 443 1:CAS:528:DC%2BD3sXmvFahtbo%3D 10.1016/S0092-8674(03)00645-7 12941272
29. S. Ortega I. Prieto J. Odajima A. Martin P. Dubus R. Sotillo J.L. Barbero M. Malumbres M. Barbacid Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice Nat Genet 2003 35 25 31 1:CAS:528:DC%2BD3sXmslelsrw%3D 10.1038/ng1232 12923533
30. C. Berthet E. Aleem V. Coppola L. Tessarollo P. Kaldis Cdk2 knockout mice are viable Curr Biol 2003 13 1775 1785 1:CAS:528:DC%2BD3sXot12itbk%3D 10.1016/j.cub.2003.09.024 14561402
31. O. Tetsu F. McCormick Proliferation of cancer cells despite CDK2 inhibition Cancer Cell 2003 3 233 245 1:CAS:528:DC%2BD3sXislOrtb0%3D 10.1016/S1535-6108(03)00053-9 12676582
32. W.A. Bresnahan I. Boldogh T. Ma T. Albrecht E.A. Thompson Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle Cell Growth Differ 1996 7 1283 1290 1:STN:280:DyaK2s%2Fks1Cisw%3D%3D 8891332
33. W.A. Bresnahan E.A. Thompson T. Albrecht Human cytomegalovirus infection results in altered Cdk2 subcellular localization J Gen Virol 1997 78 1993 1997 1:CAS:528:DyaK2sXkvFCjtrk%3D 10.1099/0022-1317-78-8-1993 9266999
34. E.S. Yang K.L. Burnstein Vitamin D inhibits G1 to S phase progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm J Biol Chem 2003 78 46862 46868 10.1074/jbc.M306340200
35. Kip1, increases its protein stability J Biol Chem 2000 275 25146 25154 1:CAS:528:DC%2BD3cXmtVeiurw%3D 10.1074/jbc.M001144200 10831586
36. G. Rodier A. Montagnoli L. Di Marcotullio P. Coulombe G.F. Draetta M. Pagano S. Meloche p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis EMBO J 2001 20 6672 6682 1:CAS:528:DC%2BD3MXptVaqtLw%3D 10.1093/emboj/20.23.6672 11726503 125773
37. Kip1and regulates cell cycle progression EMBO J 2002 21 3390 3401 1:CAS:528:DC%2BD38XlsFCgtLY%3D 10.1093/emboj/cdf343 12093740 126092
38. Kip1at threonine 157 and modulation of its cellular localization Nat Med 2002 8 1145 1152 1:CAS:528:DC%2BD38XnsVGrt70%3D 10.1038/nm759 12244301
39. J. Liang J. Zubovitz T. Petrocelli R. Kotchetkov M.K. Connor K. Han J.H. Lee S. Ciarallo C. Catzavelos R. Beniston E. Franssen J.M. Slingerland PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest Nat Med 2002 8 1153 1160 1:CAS:528:DC%2BD38XnsVGrt7s%3D 10.1038/nm761 12244302
40. Kip1by PKB/Akt-mediated phosphorylation in breast cancer Nat Med 2002 8 1136 1144 1:CAS:528:DC%2BD38XnsVGrt7g%3D 10.1038/nm762 12244303
41. Kip1at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization J Biol Chem 2003 278 49254 49260 1:CAS:528:DC%2BD3sXptlGrsb8%3D 10.1074/jbc.M306614200 14504289
42. Kip1promotes binding to 14-3-3 and cytoplasmic localization J Biol Chem 2002 277 28706 28713 1:CAS:528:DC%2BD38XmsVGqtbw%3D 10.1074/jbc.M203668200 12042314
43. O. Coqueret New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 2003 13 65 70 1:CAS:528:DC%2BD3sXmt1akuw%3D%3D 10.1016/S0962-8924(02)00043-0 12559756
44. S.I. Reed Cell cycling? Check your brakes Nat Cell Biol 2002 4 E199 E201 1:CAS:528:DC%2BD38Xls1Ort7k%3D 10.1038/ncb0802-e199 12149634
45. kip1C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions Mol Cell Biol 2003 23 216 228 1:CAS:528:DC%2BD3sXhtVOktA%3D%3D 10.1128/MCB.23.1.216-228.2003 12482975 140659
46. K. Hirano Y. Zeng M. Hirano J. Nishimura H. Kanaide Sequence requirement for nuclear localization and growth inhibition of p27Kip1R, a degradation-resistant isoform of p27Kip1 J Cell Biochem 2003 89 191 202 1:CAS:528:DC%2BD3sXjt1Wmtbo%3D 10.1002/jcb.10499 12682919